Global Liver Disease Diagnostics Market to USD 62.6 Billion by 2031: AMR

Increase in unhealthy lifestyle among people, increase in the use of drugs and overdose of narcotics among millennials, sedentary lifestyle, increase in consumption of alcohol, and rise in smoking among people drive the growth of the global liver disease diagnostics market. Surge in need to treat COVID-infected patients on priority and increase in the number of cases during the pandemic reduced the demand for liver disease diagnostics during the pandemic.


Portland, OR, Nov. 03, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Liver Disease Diagnostics Market generated $34.5 billion in 2021, and is projected to reach $62.6 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape. The report is a useful source of information for new entrants, shareholders, frontrunners, and shareholders in introducing necessary strategies for the future and taking essential steps to significantly strengthen and heighten their position in the market.

Download Free Sample Report (203 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/8790

Report coverage & details:

Report CoverageDetails
Forecast Period2022­–2031
Market Size in 2031$62.6 billion
CAGR6.1%
No. of Pages in Report203
Segments CoveredTechnique, End-Use, and Region.
Drivers Increase in unhealthy lifestyle among people
Increase in consumption of alcohol
OpportunitiesRise in demand for minimally invasive diagnostic procedure for the diagnosis of liver diseases
Rise in smoking habits among people
RestrainsExtortionate cost of treatment


COVID-19 Scenario:

  • The outbreak of COVID-19 had a negative impact on the growth of the global liver disease diagnostics market, owing to the prevalence of lockdowns in various countries across the globe.
  • Lockdowns resulted in increased focus and reliance towards COVID-19 infected patients due to the high degree of fatality rate in the disease. Thus, liver disease diagnostic treatments were either postponed or cancelled due to the rise in coronavirus cases.
  • Apart from that, the COVID-19 pandemic led to rise in awareness regarding physical, mental, and emotional health. This, in turn, has increased awareness regarding the diagnosis of liver diseases and increased regular check-ups by using liver disease diagnostics. Thus, such development is anticipated to bring stabilization and drive the growth of the liver disease diagnostic market during the forecast period.

The report offers detailed segmentation of the global liver disease diagnostics market based on technique, end-use, and region. The report provides a comprehensive analysis of every segment and their respective sub-segment with the help of graphical and tabular representation. This analysis can essentially help market players, investors, and new entrants in determining and devising strategies based on fastest growing segments and highest revenue generation that is mentioned in the report.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/8790

Based on technique, the imaging segment held the largest market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leadership status during the forecast period. The laboratory tests segment, on the other hand, is expected to cite the fastest CAGR of 6.6% during the forecast period.

Based on end-use, the hospitals segment held the dominating market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leadership status during the forecast period. The laboratories segment, on the other hand, is expected to cite the fastest CAGR of 6.6% during the forecast period.

Based on region, the market across North America held the lion’ share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leadership status during the forecast period. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 8.3% during the forecast period. The report also analysed other regions of the market such as Europe and LAMEA.

The key players analyzed in the global liver disease diagnostics market report include Abbott Laboratories, Bio-Rad Laboratories Inc., Cosara Diagnostics Pvt Ltd, Echosens, Meril Life Sciences Pvt. Ltd., PerkinElmer, Qiagen N.V., Siemen’s AG, Thermo Fisher Scientific Inc., Trivitron Healthcare.

The report analyzes these key players in the global liver disease diagnostics market. These market players have made effective use of strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is helpful in analyzing recent developments, product portfolio, business performance and operating segments by prominent players in the market. 


Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Pharmaceutical Packaging Market by Product Type (Parenteral Containers, Plastic Bottles, Blister Packaging, Closures, Specialty Bags, Labels, and Others), Material (Glass, Aluminum Foils, Plastics and Polymers, Paper & Paperboards, and Others): Opportunity Analysis and Industry Forecast, 2020-2030

In Vitro Diagnostics Market By Product And Services (Reagents, Instruments, Software And Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), by End User (Standalone Laboratories, Hospitals, Academic And Medical Schools, Point Of Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2030

Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Multiplex Assay Market by Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other Multiplex Assays), Product (Reagents & Consumables, Instruments & Accessories, and Software & Services), Application (Clinical Diagnostics, Research & Development, and Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020-2030


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


Web: https://www.alliedmarketresearch.com/reports-store/life-sciences

 

Coordonnées